No definition available.
Haemorrhagic disorder due to circulating anticoagulants
EFO MESH Endpoint Browser PheWeb
D3_HAEMORRHAGCIRGUANTICO
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
406 |
4. Check minimum number of eventsNone |
406 |
5. Include endpointsNone |
406 |
6. Filter based on genotype QC (FinnGen only) |
406 |
Control definitions (FinnGen only)
- Control exclude
- D3_COAGDEF_PURPUR_HAEMORRHAGIC
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D68
- Name in latin
- Perturbatio haemorrhagica ex anticoagulantibus circulantibus
Similar endpoints
↥List of similar endpoints to
Haemorrhagic disorder due to circulating anticoagulants
based on the number of shared cases.
Similar with more cases:
- Other coagulation defects
- Coagulation defects, purpura and other haemorrhagic conditions
- Bleeding
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4217 | 1891 | 2271 |
| Only index persons | 3038 | 1409 | 1629 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.05 | 0.06 |
| Only index persons | 0.06 | 0.05 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 78.36 | 81.68 | 75.74 |
| Only index persons | 79.55 | 82.39 | 77.09 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 406 | 146 | 260 |
| Unadjusted period prevalence (%) | 0.09 | 0.05 | 0.11 |
| Median age at first event (years) | 75.42 | 73.94 | 76.25 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 354
- Matched controls
- 3538
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
+∞
323.0
351
*
B01AA03
ATC
warfarin; systemic
14.8
108.4
284
759
I48
ICD-10 Finland
Atrial fibrillation and flutter
5.5
49.2
228
876
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
24.8
38.9
55
26
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
9.0
37.6
85
120
C03CA01
ATC
furosemide; systemic
3.1
22.8
210
1133
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
7.6
21.6
52
78
B01AB05
ATC
enoxaparin; parenteral
3.0
19.5
159
764
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
18.1
106
402
R04.0
ICD-10 Finland
Epistaxis
4.8
17.6
62
150
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
14.4
16.8
28
21
C07AB07
ATC
bisoprolol; oral
2.6
16.6
237
1537
I50.9
ICD-10 Finland
Heart failure, unspecified
2.9
16.5
121
532
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.0
16.3
113
477
K78
ICPC
Atrial fibrillation/flutter
3.8
16.0
74
231
TFP20
NOMESCO Finland
Cardiodefibrillation
4.2
15.7
63
173
AA1AD
NOMESCO Finland
CT of head and brain
2.7
15.5
143
714
C01AA05
ATC
digoxin; systemic
3.1
13.6
83
317
207
Kela drug reimbursment
Chronic arrhythmias
2.7
13.4
107
485
W19
ICD-10 Finland
Unspecified fall
3.6
13.2
62
195
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
8.4
12.9
28
36
D68.8
ICD-10 Finland
Other specified coagulation defects
134.6
12.5
13
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.3
12.1
150
851
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
22.2
12.1
17
8
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
4.1
11.8
47
127
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.3
11.3
148
856
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
10.6
11.2
21
21
I50.0
ICD-10 Finland
Congestive heart failure
2.9
10.7
68
264
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
7.2
10.6
25
37
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.1
10.4
41
110
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
18.2
9.5
14
8
I61.6
ICD-10 Finland
Intracerebral haemorrhage, multiple localized
102.7
9.5
10
*
C01BD01
ATC
amiodarone; systemic
5.0
9.3
29
62
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
4.6
8.9
30
70
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
9.3
8.1
16
18
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
3.9
8.0
32
88
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.0
7.9
114
666
WX730
NOMESCO Finland
Conventional respirator
8.3
7.7
16
20
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
7.7
178
1236
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
7.5
96
529
C03DA01
ATC
spironolactone; oral
2.4
7.3
63
290
B01AB10
ATC
tinzaparin; parenteral
3.4
7.3
34
107
UJF32
NOMESCO Finland
Coloscopy
2.0
7.1
110
655
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.8
7.1
45
174
S06.0
ICD-10 Finland
Concussion
2.7
7.1
49
200
S06.3
ICD-10 Finland
Focal brain injury
7.2
7.1
16
23
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
6.9
58
261
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.4
6.9
32
100
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
5.9
6.9
18
32
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.9
6.9
123
774
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
40.9
6.8
8
*
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
17.1
6.8
10
6
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.5
6.8
30
91
TFC25
NOMESCO Finland
Transseptal catheterisation of left atrium or ventricle
12.6
6.6
11
9
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.7
6.6
45
181
S97
ICPC
Chronic ulcer skin
3.3
6.6
32
104
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.2
6.4
32
106
I50
ICD-10 Finland
Heart failure
3.5
6.4
28
84
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
6.3
80
439
D68.0
ICD-10 Finland
Von Willebrand disease
+∞
6.3
6
*
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.9
6.2
36
133
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
12.8
6.1
10
8
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
12.8
6.1
10
8
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
8.8
6.1
12
14
WX892
NOMESCO Finland
Monitored bed care
2.8
6.1
39
152
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.7
6.0
25
72
H02AB06
ATC
prednisolone; systemic
1.7
6.0
169
1216
EBA10
NOMESCO Finland
Surgical removal of tooth
3.2
6.0
30
100
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022217) INR in Platelet poor plasma by Coagulation assay
147
550
3.62
32.05
52.2
29.1
inr
2.1
1.4
3.77
14
61
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
60
111
6.17
32.05
3.3
2.2
u/ml
0.3
0.3
0.34
41
63
(3036489) Thrombin time
47
83
6.27
26.17
4.1
1.9
s
23.7
21.7
0.40
41
78
(3032080) INR in Blood by Coagulation assay
238
1451
2.55
18.69
28.2
11.7
inr
1.8
1.4
6.46
76
410
(3012095) Magnesium [Moles/volume] in Serum or Plasma
114
522
2.65
15.96
4.8
2.9
mmol/l
0.8
0.8
0.22
103
480
(3003458) Phosphate [Moles/volume] in Serum or Plasma
98
428
2.70
14.98
5.6
5.1
mmol/l
1.0
1.0
0.42
92
387
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
169
993
2.20
13.06
3.3
2.0
u/l
223.8
347.1
0.76
161
933
(4306422)
15
16
9.70
12.62
1.3
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
20
8.29
11.96
1.1
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
173
1066
2.09
11.47
5.8
4.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
98
513
2.20
9.68
3.2
2.4
g/l
2.2
2.2
0.32
86
470
(3033658) Prothrombin time (PT) actual/Normal
127
743
2.03
9.33
7.8
3.9
%
71.4
82.8
3.30
120
723
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
93
488
2.17
9.08
3.7
2.5
%
18.6
21.1
1.17
82
426
(3022948) Iron [Moles/volume] in Serum or Plasma
102
559
2.10
8.89
3.4
2.4
umol/l
10.1
11.9
2.23
92
512
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
125
748
1.97
8.50
3.4
2.6
—
—
—
0
0
(4268621)
11
13
8.67
8.50
2.6
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
145
925
1.88
8.07
3.2
2.1
mg/l
3.5
3.2
0.70
122
781
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
44
176
2.68
7.80
1.5
1.6
g/l
1.8
1.7
0.37
39
160
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
13
21
6.36
7.76
1.6
1.1
u/ml
8.4
5.1
—
5
10
(3027945) Reticulocytes/100 erythrocytes in Blood
84
453
2.08
7.55
2.1
2.2
%
1.8
1.7
0.20
64
405
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
67
333
2.21
7.40
5.4
3.0
ng/l
452.5
282.5
1.73
61
304
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
210
1530
1.77
7.37
9.0
5.9
mmol/l
1.2
1.2
4.68
192
1360
(3004588) Protein electrophoresis panel - Serum or Plasma
55
253
2.36
7.28
1.6
2.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
8
14.09
6.92
1.4
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
29
99
3.08
6.84
2.9
2.8
nmol/l
0.7
1.0
1.59
22
77
(3007853) Bacteria identified in Skin by Aerobe culture
73
387
2.08
6.83
2.2
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
150
1014
1.76
6.65
3.7
2.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
43
185
2.48
6.58
9.4
10.1
mmol/l
24.2
24.6
0.27
38
168
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
79
444
1.97
6.27
9.4
7.6
kpa
5.0
5.1
0.21
73
422
(3027801) Oxygen [Partial pressure] in Arterial blood
79
445
1.96
6.22
9.4
7.6
kpa
10.9
11.3
0.33
72
424
(3003396) Base excess in Arterial blood by calculation
78
440
1.96
6.11
9.5
7.7
mmol/l
1.1
1.3
0.13
63
332
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
19
53
3.71
6.11
1.1
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
121
793
1.75
5.86
3.4
2.8
umol/l
404.8
6486.7
3.30
100
667
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
63
336
2.04
5.77
3.0
2.5
ug/l
6.2
6.5
0.06
53
291
(3023520) Reticulocytes [#/volume] in Blood
62
330
2.04
5.71
2.3
2.2
e9/l
66.3
65.2
0.12
41
269
(3052851) Hemolysis interference index of Serum or Plasma
26
95
2.86
5.48
3.0
4.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
70
395
1.93
5.46
9.7
8.1
%
94.1
94.8
0.23
64
381
(42870588) Differential panel, method unspecified - Blood
138
956
1.67
5.38
6.4
4.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
53
273
2.08
5.32
6.2
5.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
214
1658
1.61
5.31
9.9
6.5
mmol/l
1.2
1.2
4.55
172
1370
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
80
2.99
5.28
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
80
2.99
5.28
1.4
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
16
44
3.74
5.25
6.8
6.3
mg/l
10.9
12.3
0.51
16
39
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
64
362
1.91
4.94
5.2
3.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
183
1382
1.59
4.94
5.1
4.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
168
1247
1.59
4.86
5.7
3.2
ng/l
3003.5
2140.1
1.58
140
1075
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
33
4.04
4.74
1.4
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
190
1460
1.57
4.69
6.2
4.4
g/l
32.2
34.3
5.08
174
1346
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
182
1392
1.56
4.54
6.6
4.2
ng/l
42.1
46.1
0.24
153
1086
(3019309) Folate [Moles/volume] in Red Blood Cells
116
798
1.64
4.54
2.0
1.8
nmol/l
1288.9
1176.1
0.41
81
599
(40760888) Immunoglobulin light chains.free panel - Serum
21
78
2.78
4.32
2.6
3.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
96
638
1.66
4.27
2.3
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
209
1666
1.52
4.22
7.9
5.6
umol/l
13.2
11.9
1.11
198
1562
(3012501) Base excess in Blood by calculation
22
85
2.68
4.21
5.7
5.1
mmol/l
2.0
2.6
0.57
12
56
(3018418) pH of Serum or Plasma
139
1014
1.56
4.21
5.3
3.7
ph
7.4
7.4
0.75
32
195
(3022806) Fractional oxyhemoglobin in Capillary blood
15
47
3.28
4.09
2.1
2.0
%
89.6
89.1
0.13
15
47
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
28
124
2.35
4.07
1.9
2.5
g/l
0.4
0.5
0.10
23
106
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
93
623
1.64
4.00
4.8
1.7
mg/l
1.9
1.5
0.41
74
490
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
48
266
1.91
3.94
2.1
1.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
166
1274
1.51
3.93
7.5
5.2
%
0.6
0.6
0.19
152
1175
(3006504) Eosinophils/100 leukocytes in Blood
169
1303
1.51
3.91
7.5
5.1
%
2.6
2.8
0.30
155
1198
(3002030) Lymphocytes/100 leukocytes in Blood
172
1335
1.50
3.84
7.6
5.4
%
21.4
24.8
3.80
156
1220
(3019069) Monocytes/100 leukocytes in Blood
169
1309
1.50
3.80
7.7
5.4
%
9.0
9.0
0.04
154
1213
(3037522) Nuclear Ab [Titer] in Serum
51
293
1.85
3.76
1.4
1.3
titre
790.0
498.7
—
8
60
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
26
117
2.31
3.66
3.0
3.0
mg/l
36.9
33.0
0.25
21
94
(3013826) Glucose [Moles/volume] in Serum or Plasma
230
1910
1.47
3.57
7.5
5.0
mmol/l
7.2
6.9
0.65
220
1795
(40757373) Influenza virus identified in Isolate
6
6
10.12
3.50
2.0
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
42
3.16
3.40
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
13
42
3.16
3.40
1.2
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
167
1313
1.46
3.39
7.3
5.2
%
63.6
59.6
4.17
154
1213
(3026782) Osmolality of Urine
101
717
1.54
3.36
4.2
3.2
mosm/kgh2o
522.2
560.1
1.24
88
606
(3019198) Lymphocytes [#/volume] in Blood
178
1420
1.45
3.33
7.5
5.1
e9/l
1.5
1.7
3.10
153
1244
(3001604) Monocytes [#/volume] in Blood
174
1387
1.45
3.25
7.3
4.9
e9/l
0.7
0.6
1.40
148
1182
(3037756) Immunofixation for Serum or Plasma
20
85
2.42
3.20
1.3
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
180
1447
1.44
3.20
7.4
5.0
e9/l
0.2
0.2
0.20
159
1257
(3006315) Basophils [#/volume] in Blood
174
1395
1.43
3.12
7.4
4.9
e9/l
0.0
0.0
0.28
150
1198
(3012441) Differential panel - Pleural fluid
13
46
2.89
2.94
1.1
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
142
1108
1.43
2.91
3.9
3.1
mmol/l
2.3
2.3
1.90
116
955
(3000991) Gas panel - Venous blood
48
294
1.72
2.88
11.2
8.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
144
2.01
2.88
1.9
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
144
2.01
2.88
1.9
2.1
g/l
7.9
7.5
0.40
22
109
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
144
2.01
2.88
1.9
2.1
g/l
4.4
3.7
1.56
22
107
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
39
225
1.81
2.86
6.8
3.7
mmol/l
3.1
2.2
0.42
29
162
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
32
174
1.91
2.82
12.1
12.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
151
1198
1.41
2.80
3.9
2.7
ug/l
165.9
163.6
0.04
129
1068
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
139
2.01
2.77
1.9
2.2
g/l
4.0
3.2
1.85
22
108
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
72
2.42
2.76
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
30
161
1.93
2.75
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
24
3.81
2.68
1.2
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
45
695
0.60
2.64
1.8
1.6
mmol/l
1.4
1.4
0.16
40
557
(40767503) Oxygen content in Capillary blood by calculation
17
74
2.35
2.61
4.2
2.2
%
15.4
15.4
—
5
34
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
24
121
2.05
2.61
1.5
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
128
997
1.41
2.60
2.8
2.4
u/l
57.5
57.4
0.00
117
919
(3042936) Bacteria identified in Isolate by Culture
72
501
1.53
2.60
2.8
2.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
136
1073
1.40
2.57
3.6
3.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
13
50
2.65
2.55
2.2
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
65
447
1.54
2.47
2.2
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
31
175
1.84
2.46
6.1
3.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
248
2771
0.73
2.41
4.8
5.2
mmol/l
2.3
2.5
3.74
206
2465
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
91
2.14
2.37
1.4
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
8
200
0.39
2.36
3.0
4.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
22
112
2.02
2.35
2.4
2.9
g/l
0.4
0.3
—
9
35
(3000850) Epithelial cells [#/volume] in Urine
99
750
1.42
2.33
3.7
2.7
e6/l
7.1
4.3
0.47
89
656
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
41
256
1.67
2.32
3.6
3.7
ng/l
126.0
89.9
1.41
33
225
(3019230) Fractional oxyhemoglobin in Venous blood
13
53
2.50
2.30
2.1
2.2
%
43.2
58.6
1.07
13
53
(3009343) pH of Capillary blood
39
241
1.68
2.29
6.8
3.6
ph
7.4
7.4
—
5
24
(3008152) Bicarbonate [Moles/volume] in Arterial blood
41
258
1.66
2.26
10.0
7.0
mmol/l
25.3
24.1
0.98
35
240
(40768797) Stomach Pathology biopsy report
56
381
1.54
2.24
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
29
3.15
2.24
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
94
712
1.42
2.21
7.6
6.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
237
2652
0.74
2.21
4.7
4.6
mmol/l
1.3
1.4
2.10
195
2351
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
54
368
1.54
2.15
2.9
2.6
umol/l
10.4
8.4
0.28
48
324
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
27
153
1.82
2.14
2.3
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
56
786
0.67
2.12
3.1
3.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
241
2683
0.75
2.11
4.5
4.6
mmol/l
4.1
4.3
3.52
203
2407
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
37
231
1.66
2.11
1.5
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
113
890
1.37
2.11
4.5
2.9
u/l
33.2
34.3
0.14
99
851
(40768443) Skin Pathology biopsy report
25
139
1.85
2.10
1.2
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
27
154
1.81
2.10
1.9
1.7
ug/l
2.2
3.8
0.28
20
129
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
20
3.54
2.06
1.4
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
22
118
1.91
2.06
3.8
2.9
pmol/l
3.6
4.3
2.25
17
104
(3016018) Differential panel - Cerebral spinal fluid
6
15
4.04
2.04
1.3
1.1
—
—
—
0
0
(3012544) pH of Venous blood
52
356
1.53
2.03
4.4
3.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
40
258
1.61
2.02
1.9
1.7
nmol/l
370.6
395.0
0.27
35
228
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
51
2.39
1.97
4.3
3.0
%
63.4
60.9
0.30
12
51
(3000570) Elastase.pancreatic [Mass/mass] in Stool
15
71
2.16
1.94
1.1
1.5
ug/g
337.4
277.1
—
10
41
(3020876) Protein [Mass/time] in 24 hour Urine
8
27
3.00
1.94
2.0
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
62
447
1.46
1.90
2.2
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
111
886
1.35
1.89
4.5
3.4
—
—
—
0
0
(3020891) Body temperature
26
152
1.76
1.88
5.7
4.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
34
2.68
1.87
1.0
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
50
347
1.50
1.85
4.5
3.8
mmol/l
2.1
1.9
0.09
41
270
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
146
1219
1.31
1.81
5.0
3.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
191
1653
1.29
1.81
10.3
8.0
e9/l
4.6
4.4
0.78
169
1433
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
23
3.08
1.80
1.9
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
241
2659
0.77
1.80
6.4
6.6
mmol/mol
42.0
41.6
0.25
198
2419
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
24
139
1.77
1.80
2.0
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
249
2735
0.77
1.79
4.6
5.0
mmol/l
6.1
6.2
0.04
197
2418
(40761536) Microorganisms panel - Urine sediment
40
267
1.55
1.77
6.1
3.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
110
1339
0.76
1.74
2.9
2.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
30
2.70
1.73
1.1
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
24
2.95
1.73
2.0
4.0
—
—
—
0
0
(3000012) Reticulocyte production index
7
24
2.95
1.73
1.3
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
36
237
1.57
1.69
2.0
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
49
2.28
1.65
4.5
2.9
e9/l
5.6
4.9
0.30
11
49
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
20
3.03
1.58
1.5
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
57
2.14
1.56
2.0
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
33
2.45
1.54
1.0
1.2
nmol/l
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
15
3.36
1.53
1.0
1.1
nmol/l
145.8
122.6
—
5
15
(3002179) Metamyelocytes/100 leukocytes in Blood
31
203
1.57
1.51
5.5
3.3
%
0.4
0.4
—
10
53
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
87
692
1.33
1.50
6.6
3.9
ng/l
214.2
288.1
0.25
76
602
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
234
2565
0.79
1.50
4.2
4.2
mmol/l
1.3
1.2
0.35
194
2255
(3030467) Casts [#/volume] in Urine by Automated count
115
953
1.29
1.47
4.6
3.4
e6/l
0.4
0.5
0.57
98
738
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
45
2.25
1.47
2.3
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
38
2.40
1.46
1.7
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
7
28
2.53
1.46
1.4
1.1
u/l
51.0
40.7
—
7
18
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
16
3.15
1.44
2.2
3.6
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
16
3.15
1.44
1.2
1.7
u/field
1.4
4.5
—
5
11
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
187
1647
1.25
1.44
3.9
3.0
u/l
68.2
55.7
1.12
167
1491
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
40
281
1.47
1.43
5.4
3.3
mmol/l
1.2
1.2
2.25
33
243
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
29
2.44
1.40
1.1
1.7
—
—
—
0
0
(4035726)
37
258
1.48
1.37
1.3
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
31
208
1.53
1.37
1.9
1.7
%
1.5
1.6
0.10
26
175
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
23
2.63
1.37
2.3
2.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
17
2.96
1.36
3.0
2.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
68
1.94
1.35
2.1
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
83
1.84
1.33
7.1
4.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
34
2.38
1.30
2.6
2.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
44
2.07
1.27
1.6
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
14
77
1.85
1.27
3.2
3.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
77
1.85
1.27
1.9
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
36
2.25
1.25
2.4
4.0
—
—
—
0
0
(3000492) Spirometry study
31
213
1.49
1.25
1.7
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
244
2638
0.81
1.24
32.5
16.9
ml/min/173m2
67.7
71.5
1.54
218
2207
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
51
386
1.37
1.23
3.5
4.2
ug/l
3.3
40.9
1.17
42
326
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
85
694
1.28
1.22
3.8
3.1
mmol/l
2.5
2.5
0.02
68
605
(3002582) Erythrocytes [#/volume] in Urine
123
1051
1.24
1.21
4.9
3.6
e6/l
104.2
129.7
0.10
106
835
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
86
1.77
1.20
2.1
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
20
125
1.63
1.20
8.9
3.4
mmol/l
4.0
4.0
0.06
20
115
(3019225) pH of Specimen
42
310
1.40
1.18
5.5
4.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
33
0.00
1.16
0.0
4.0
—
50.7
—
0
28
(3022621) pH of Urine by Test strip
13
221
0.57
1.16
5.8
3.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
39
2.07
1.16
1.1
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
20
2.52
1.15
2.8
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
20
2.52
1.15
4.6
15.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
20
2.52
1.15
1.0
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
14
80
1.78
1.14
3.8
2.0
g/l
117.6
130.6
—
9
56
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
31
2.28
1.11
1.1
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
31
2.28
1.11
1.1
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
31
2.28
1.11
1.1
1.6
—
—
—
0
0
(4062490)
5
21
2.40
1.09
1.2
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
32
2.21
1.08
1.0
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
75
1.76
1.04
1.9
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
47
1.94
1.02
2.4
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
32
232
1.41
1.01
3.3
3.3
g/l
120.7
125.4
0.55
32
227
(3026389) Candida sp identified in Specimen by Organism specific culture
7
35
2.02
1.00
1.1
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
32
233
1.41
0.99
6.0
3.4
%
0.6
0.9
0.32
11
73
(3004616) Nuclear Ab [Presence] in Serum
5
23
2.19
0.98
1.2
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
36
1.96
0.97
2.6
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
50
1.82
0.97
3.8
2.7
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
11
62
1.80
0.95
1.2
1.2
—
66.0
—
0
5
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
27
2.24
0.94
1.3
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
40
307
1.34
0.91
1.4
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
30
220
1.39
0.90
6.3
3.4
%
0.1
0.1
—
10
66
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
13
79
1.67
0.89
1.8
1.6
iu/ml
0.1
0.1
—
5
21
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
95
1.60
0.88
1.4
1.2
—
—
—
0
0
(4146454)
6
31
1.95
0.84
2.3
3.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
31
1.95
0.84
1.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
45
1.79
0.84
2.4
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
132
1174
1.18
0.84
5.6
4.1
e6/l
63.9
192.7
1.22
107
889
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
180
1.41
0.84
2.4
2.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
28
206
1.39
0.84
6.6
3.5
%
0.0
0.1
—
9
58
(3037467) Urinalysis macro (dipstick) panel - Urine
226
2103
1.17
0.82
6.2
4.7
—
—
—
0
0
(44790047)
6
32
1.89
0.82
2.3
1.4
—
—
—
0
0
(44806118)
6
32
1.89
0.82
2.3
1.4
—
—
—
0
0
(44790049)
6
32
1.89
0.82
2.3
1.4
—
—
—
0
0
(44790048)
6
32
1.89
0.82
2.3
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
132
1468
0.85
0.80
7.1
5.8
estimate
0.0
0.0
0.00
37
281
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
250
2348
1.17
0.80
11.5
7.0
u/l
85.7
80.2
0.95
233
2174
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
123
0.56
0.79
1.9
5.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
48
1.68
0.79
1.8
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
48
1.68
0.79
1.5
1.6
pg
32.0
33.0
—
8
48
(3002385) Erythrocyte distribution width [Ratio]
211
2262
0.86
0.79
43.0
21.6
%
14.8
14.0
11.18
203
2212
(21494755) Public health laboratory ask at order entry panel
5
99
0.50
0.78
1.2
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
31
235
1.35
0.78
3.1
3.4
ml/min/173m2
54.5
55.8
0.10
22
101
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
48
388
1.27
0.78
18.3
8.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
31
236
1.34
0.77
1.7
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
34
1.78
0.76
2.5
2.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
56
671
0.81
0.75
5.6
4.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
54
1.68
0.75
2.1
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
209
2236
0.87
0.74
43.8
23.5
g/l
328.8
331.3
3.27
201
2212
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
55
1.65
0.74
1.3
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
109
0.54
0.73
1.3
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
28
212
1.34
0.72
1.9
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
285
2978
0.86
0.72
15.2
10.6
u/l
24.7
24.2
0.24
261
2845
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
57
1.59
0.71
1.2
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
57
1.59
0.71
1.1
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
26
1.93
0.71
1.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
93
1.52
0.70
1.2
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
57
676
0.82
0.70
7.4
4.8
kg/l
1.0
1.0
—
10
98
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
85
1.55
0.69
1.8
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
42
1.68
0.68
1.9
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
94
1.51
0.67
1.4
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
28
1.80
0.66
1.0
1.1
pmol/l
179.0
236.0
—
5
21
(3035350) Ketones [Presence] in Urine by Test strip
135
1476
0.87
0.63
5.6
4.2
estimate
0.0
0.0
0.00
37
287
(3009261) Glucose [Presence] in Urine by Test strip
136
1485
0.87
0.62
5.6
4.4
estimate
0.0
0.0
0.00
36
272
(42529406) Shigella sp [Presence] in Stool by Culture
14
96
1.47
0.62
1.4
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
122
1.41
0.61
2.2
2.9
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.3
—
0.1
—
0
13
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
21
0.00
0.60
0.0
3.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
22
0.00
0.59
0.0
2.2
—
7.3
—
0
13
(40768804) Tissue Pathology biopsy report
124
1128
1.14
0.58
2.3
2.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
37
1.63
0.55
1.7
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
122
0.65
0.55
1.6
2.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
244
2554
0.89
0.54
4.9
4.4
mu/l
2.1
2.0
0.17
202
2245
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
39
1.55
0.53
1.7
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
39
1.55
0.53
1.7
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
39
1.55
0.53
1.7
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
39
1.55
0.53
1.7
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
22
170
1.31
0.52
2.6
3.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
40
1.51
0.52
1.7
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
45
383
1.20
0.49
1.2
1.3
iu/ml
46.9
41.4
0.08
14
127
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
15
199
0.74
0.47
2.0
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
68
1.48
0.47
1.6
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
103
1125
0.89
0.46
3.7
4.7
%
23.4
21.7
0.48
47
578
(3021589) Normoblasts [#/volume] in Blood
135
1253
1.12
0.46
15.5
10.1
e9/l
0.0
0.0
0.27
105
1025
(40761535) Cells panel - Urine sediment
35
294
1.21
0.44
4.7
3.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
62
549
1.15
0.44
4.3
3.3
e6/l
1.7
1.8
0.05
37
332
(3029937) Albumin [Presence] in Urine by Test strip
92
840
1.12
0.41
5.8
4.5
estimate
0.0
0.0
0.00
33
266
(21494890) Protein electrophoresis panel - 24 hour Urine
5
33
1.52
0.41
1.2
2.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
5
34
1.48
0.40
1.8
1.2
%
62.8
67.7
—
5
27
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
34
1.48
0.40
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
251
2417
1.10
0.40
37.1
19.2
%
36.6
38.3
1.51
141
1471
(4010399)
24
196
1.24
0.40
1.5
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
13
97
1.35
0.40
2.1
2.7
u/ml
43.6
44.7
0.02
13
90
(3013512) EKG study
109
1008
1.11
0.39
6.3
4.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
40
345
1.18
0.39
1.7
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
108
1164
0.90
0.39
6.2
4.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
36
1.39
0.38
1.4
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
302
3098
0.90
0.38
48.7
25.6
g/l
125.1
132.3
10.25
289
3026
(3010813) Leukocytes [#/volume] in Blood
302
3098
0.90
0.38
48.3
25.4
e9/l
7.5
7.0
3.62
285
2988
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
68
1.33
0.38
3.7
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
37
1.36
0.37
1.2
1.7
—
—
—
0
0
(3035941) MCH [Entitic mass]
302
3096
0.90
0.36
48.1
25.3
pg
30.3
30.4
0.41
287
3030
(3026361) Erythrocytes [#/volume] in Blood
302
3096
0.90
0.36
48.3
25.4
e12/l
4.2
4.4
6.55
284
2986
(3024731) MCV [Entitic volume]
302
3095
0.91
0.36
48.2
25.3
fl
92.0
91.7
0.41
287
3030
(40760892) CBC W Ordered Manual Differential panel - Blood
63
568
1.13
0.35
6.3
4.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
302
3094
0.91
0.35
48.3
25.4
e9/l
230.4
236.4
0.69
284
3000
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
45
1.34
0.34
1.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
45
1.34
0.34
3.8
2.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
286
2935
0.91
0.33
33.1
16.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
33
285
1.17
0.33
1.8
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
84
775
1.11
0.32
1.8
1.8
pmol/l
418.1
9135047.6
0.50
57
624
(3003694) ABO and Rh group [Type] in Blood
73
669
1.11
0.32
1.4
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
52
1.35
0.31
1.1
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
201
2087
0.93
0.30
6.1
4.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
52
469
1.12
0.30
1.9
1.4
g/l
2.7
2.8
0.11
36
263
(3003327) Ova and parasites identified in Stool by Light microscopy
8
65
1.24
0.27
1.5
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
75
1.20
0.25
7.9
2.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
95
1006
0.93
0.24
4.2
4.1
mg/mmol
24.5
10.3
0.77
61
660
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
38
1.32
0.23
2.2
3.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
39
1.29
0.23
1.4
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
39
1.29
0.23
2.8
4.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
3.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
3.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
10
0.00
0.21
0.0
1.1
—
2.2
—
0
10
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
1.0
—
0
5
(40765096) Chromosome analysis panel by Banding
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
12
0.00
0.21
0.0
2.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
43
1.16
0.21
1.4
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
13
0.00
0.21
0.0
1.1
—
8.1
—
0
13
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(4027681)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
13
0.00
0.21
0.0
3.2
—
52.4
—
0
5
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
61
569
1.08
0.20
3.4
3.0
e6/l
0.7
1.1
1.25
35
348
(3021960) Folate [Moles/volume] in Serum or Plasma
83
877
0.93
0.20
1.7
1.7
nmol/l
18.7
20.4
0.47
69
733
(3042631) Mycobacterium sp identified in Specimen
6
51
1.18
0.19
3.0
3.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
28
251
1.12
0.19
2.4
2.1
ug/g
396.4
142.4
0.81
18
202
(3009508) Creatinine [Moles/volume] in Urine
91
955
0.94
0.18
3.2
3.2
mmol/l
6.3
7.1
1.41
66
774
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
59
1.19
0.18
1.1
1.1
—
20.5
—
0
5
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
38
349
1.10
0.18
1.2
1.3
u/ml
23.1
15.2
0.19
13
120
(3002256) Pathology report gross observation
42
388
1.09
0.17
1.3
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
90
943
0.94
0.17
3.2
3.2
mg/l
821.5
233.6
0.41
64
630
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
24
267
0.89
0.17
1.2
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
292
2875
1.06
0.17
36.1
17.7
mg/l
32.0
28.0
1.39
268
2368
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
120
1.17
0.16
1.4
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
298
3022
0.95
0.16
40.1
21.3
mmol/l
4.0
4.0
0.90
279
2933
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
137
1415
0.95
0.16
4.4
5.4
ug/l
6.3
3.0
0.61
114
1225
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
48
511
0.93
0.15
1.1
1.2
u/ml
0.8
1.1
—
8
123
(3019550) Sodium [Moles/volume] in Serum or Plasma
298
3018
0.95
0.14
40.2
21.2
mmol/l
139.1
139.6
1.84
279
2929
(3013707) Erythrocyte sedimentation rate by Westergren method
221
2171
1.04
0.12
5.9
4.0
mm/h
24.0
14.9
5.89
192
1954
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
152
1.12
0.12
1.1
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
123
1196
1.04
0.11
2.5
2.2
nmol/l
77.3
78.7
0.21
100
1038
(3041096) Erythrocytes [Presence] in Urine by Automated
79
819
0.96
0.11
5.6
4.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
249
0.92
0.10
1.6
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
47
1.06
0.09
1.2
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
10
113
0.88
0.08
10.6
2.5
mmol/l
29.0
24.5
—
10
91
(4094501)
5
61
0.82
0.08
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
67
1.05
0.08
3.3
2.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
101
0.89
0.06
1.8
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
16
170
0.94
0.04
1.2
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
19
181
1.05
0.03
4.3
3.0
e9/l
4.3
3.8
0.30
12
129
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
37
380
0.97
0.03
4.4
4.7
%
30.9
32.5
0.38
23
244
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
202
2033
0.99
0.03
4.2
3.6
pmol/l
15.3
15.1
0.31
170
1778
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
142
1412
1.01
0.01
2.5
2.1
pmol/l
86.0
91.7
0.95
79
738
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
138
1.02
0.00
1.4
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
15
148
1.01
0.00
3.9
3.3
u/ml
347.1
1314.3
—
10
123
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
111
0.99
0.00
1.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
80
804
0.99
0.00
3.0
3.1
ug/l
0.8
0.8
0.32
54
555
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
8.8
—
1076.5
—
0
8
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
55
0.91
0.00
1.0
1.2
u/l
28.4
55.1
—
5
46
(3033799) Differential panel - Peritoneal fluid
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
10.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
10.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
10.1
—
1626.9
—
0
8
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
28.2
—
0
8
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
97.1
—
0
6
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
8
0.00
0.00
0.0
1.0
—
26.0
—
0
8
(3000285) Sodium [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
7
0.00
0.00
0.0
2.0
—
1.2
—
0
7
(3015183) Erythrocyte sedimentation rate
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
15.9
—
0
5
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
90
1.00
0.00
1.7
1.7
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
6
65
0.92
0.00
1.3
1.5
mg/l
19.5
12.8
—
6
56
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4034850)
11
110
1.00
0.00
36.7
11.9
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
44.8
—
0
5
(3028626) Oxygen [Partial pressure] in Capillary blood
9
96
0.94
0.00
8.4
2.2
kpa
8.0
7.7
—
9
82
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
18.3
—
0
9
(40768800) Prostate Pathology biopsy report
8
80
1.00
0.00
1.3
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
61
0.98
0.00
1.0
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
69
1.01
0.00
1.4
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
10.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
83
0.96
0.00
1.6
1.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
84.3
—
0
5
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
7
0.00
0.00
0.0
2.7
—
13.2
—
0
7
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_HAEMORRHAGCIRGUANTICO and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_HAEMORRHAGCIRGUANTICO | 2.704 [1.88, 3.89] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.013 |
During the follow-up period (1.1.1998 — 31.12.2019), 199 out of 431 females with D3_HAEMORRHAGCIRGUANTICO died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_HAEMORRHAGCIRGUANTICO | 2.812 [1.94, 4.07] | < 0.001 |
| Birth year | 0.982 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 229 out of 470 males with D3_HAEMORRHAGCIRGUANTICO died.
Mortality risk
Mortality risk for people of age
years, who have D3_HAEMORRHAGCIRGUANTICO.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.18% | 0.516% |
| 5 | 1.195% | 2.941% |
| 10 | 3.153% | 7.068% |
| 15 | 5.678% | 12.913% |
| 20 | 10.172% | 21.439% |
Relationships between endpoints
↥Index endpoint: D3_HAEMORRHAGCIRGUANTICO – Haemorrhagic disorder due to circulating anticoagulants
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data